The early-stage study will test the drug’s safety, tolerability and biological effects in humans
The approval marks a major advance in targeted treatment for this rare, chronic autoimmune disease, offering twice-yearly maintenance dosing after two initial loading doses
AbbVie receives the option to license worldwide rights to CUG252 from Cugene, a clinical-stage and potential best-in-class Treg-selective IL-2 mutein, building on AbbVie's commitment to developing novel therapies in immunology
Researchers at the Feinstein Institutes administer extra vaccine doses as part of the NIH funded study
Initiative focuses on early diagnosis, gut health awareness and long-term gluten-free care for children with celiac disease
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
The initiative by Rheumatology Association of Gujarat is aimed at strengthening patient-centric autoimmune care
The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases
The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
Subscribe To Our Newsletter & Stay Updated
